BioQuark's plans postponed
The Indian authorities have banned the experiment on the "resurrection" of corpses
The scandalous experiment by BioQuark to revive a person in a state of clinical death has been officially banned by the Indian authorities, the news service of the journal Science (Experiment to raise the dead blocked in India) reports.
In the spring of this year, the US regulatory authorities issued BioQuark the first permit in the history of medicine for experiments in which employees of this company will try to restore part of the brain functions using a synthetic protein codenamed BQ-A, special stem cells, laser brain stimulation and electrical stimulation of the median nerve.
The experiments themselves, as originally planned by BioQuark specialists, were to be conducted not in the USA, but in India, at the Rudrapur hospital, where scientists planned to recruit a group of 20 "volunteers" in a state of clinical death, whose relatives agreed to donate the bodies of the deceased for scientific experiments.
Strokes and various head injuries often put a person in a condition that doctors call "brain death". In such cases, the patient's body still lives if it is supported by artificial respiration devices and waste disposal, but the brain is no longer functioning. In fact, a person in such a state can already be recognized as dead, since he cannot live independently.
The reason for the onset of "brain death", as scientists from BioQuark explain, is that the lower parts of the brain stem, located at the base of the neck and critically important for human life, die as a result of injury or chronic lack of oxygen. Their death, as a rule, is fatal for a person, since without them our body is not even able to breathe independently and control the work of the heart.
Using BQ-A injections, stem cells and laser pulses, scientists hoped to "restart" the brains of deceased Indians, but this, apparently, will never happen again – this week the Indian Council for Medical Research (ICMR) removed experiments codenamed ReAnima from the list of experiments that were to be conducted in India this year.
According to ICMR representatives, this decision was made for formal reasons – BioQuark and its Indian partners did not receive permission to conduct such experiments from the Chief Pharmacist of India, who must approve the use of BQ-A and other drugs that scientists planned to use.
The story could have ended there, but the decision to terminate the experiment itself is the prerogative of the Chief Pharmacist, who has not yet commented on the ICMR decision and has not talked about a possible ban or permission of the experiments.
BioQuark representatives themselves, as Science reports, do not consider such a ban a problem, since in this case they will simply transfer the experiment to more friendly countries. The successful completion of these experiments, scientists hope, will pave the way for more ambitious projects to save the brain from death as a result of coma, vegetative state and various degenerative brain diseases.
Portal "Eternal youth" http://vechnayamolodost.ru
16.11.2016